PodcastIntel
Sign in Get Started Free
Dr. Alex Tatem

Retatrutide Dosing Explained (Doctor Breaks Down the Data)

Jun 2, 2026 · 0:18:27
Listen to Episode
✨ AI Summary
  • Retatrutide shows significant weight loss in Phase 3 trials.
  • It's a triple-agonist drug outperforming some GLP-1s.
  • Dr. Tatem breaks down the TRIUMPH-1 data and dosing.

More from Dr. Alex Tatem

Sermorelin: The “Safer HGH” Has One Huge Problem
Aug 18, 2026 · 0:25:00
Primobolan: The Steroid Everyone Gets Wrong
Aug 12, 2026 · 0:26:45
Doctor Reacts to Clav’s Insane Drug Stack
Aug 10, 2026 · 0:02:15
The Truth About NAD (From a Doctor)
Aug 4, 2026 · 0:22:07
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Dr. Alex Tatem and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →